Showing 28,921 - 28,940 results of 29,240 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.69s Refine Results
  1. 28921

    Image_2_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  2. 28922

    Image_4_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  3. 28923

    Image_3_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  4. 28924

    Image_1_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  5. 28925

    <i>Theileria annulata</i> parasites with M128I mutation in cytochrome B (<i>Ta</i>M128I) resist buparvaquone treatment. by Shahin Tajeri (3609266)

    Published 2024
    “…A clear right shift in dose-response curve resulted from decreased susceptibility of macrophages transformed by <i>Ta</i>M128I parasite compared to the wild type is detectable. …”
  6. 28926

    Activity and Reactivity of Fe<sup>2+</sup> Cations in the Zeolite. Ab Initio Free-Energy MD Calculation of the N<sub>2</sub>O Dissociation over Iron-Exchanged Ferrierite by Lubomir Benco (1987384)

    Published 2009
    “…The MD simulations show that the bivalent Fe<sup>2+</sup> cation can induce a local deformation of the zeolite framework, which cannot be observed experimentally. …”
  7. 28927

    AOX inhibitor supresses growth of <i>T</i>. <i>hominis</i> cells inside the RK13 host cells at early meront stages of the infection, and affects the ability to infect by the spores... by Kacper M. Sendra (14285356)

    Published 2022
    “…<p>Effects of the two clinically used anti-microsporidian drugs (albendazole, 350 nM; and fumagillin, 200 nM), and an inhibitor of the AOX Colletochlorin B (CCB, 50 μM) on progression of the parasite life cycle were tested in a synchronised time course of infection in <i>T</i>. …”
  8. 28928

    Factors affecting the rate of asymmetry between the minus and the plus strands. by Gergely Boza (298386)

    Published 2014
    “…The results are averaged over 5 replicate model runs, and over 1,000,000 molecular update steps after reaching equilibrium. …”
  9. 28929

    Increased aggregation propensity enhances Pept-in antimicrobial potency by promoting Pept-in accumulation and IB formation. by Guiqin Wu (760045)

    Published 2023
    “…This figure is associated with data from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0283674#pone.0283674.s009" target="_blank">S3 Table</a>. …”
  10. 28930

    Lung-Sparing Surgery for Treatment of Pulmonary Metastases: VATS Right Anterior Segmentectomy (S3) and RLL Wedge Resection by Andres Obeso (4544185)

    Published 2020
    “…</p><p>Dissection and section of the venous branch (V3) for the anterior segment:<br>Sometimes two independent venous branches (V3a and V3b) can be identified arising from the central vein.…”
  11. 28931

    S1 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  12. 28932

    S3 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  13. 28933

    S2 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  14. 28934

    S5 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  15. 28935

    S6 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  16. 28936

    S4 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  17. 28937

    S7 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  18. 28938

    TAp63 and p53 mutants display reduced proliferation in basal layers and reduced differentiation in upper layers of tubercle remnants. by Boris Fischer (507766)

    Published 2014
    “…(F) Distribution of phenotypic strengths (n, normal; C1, intermediate; C2, strong) in lower jaw tubercles of wild-type, TAp63 mutant, p53 mutant and TAp63/p53 double mutant fish at an age of 50 days (upper panel) and 1 year (lower panel), determined via calcein staining (for example, see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004048#pgen-1004048-g008" target="_blank">Figure 8V,X</a>). …”
  19. 28939

    Table_1_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  20. 28940

    Table_3_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”